EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

Abstract

The EUROASPIRE III survey shows that large proportions of coronary patients do not achieve the lifestyle, risk factor and therapeutic targets for cardiovascular disease prevention. Wide variations in risk factor prevalences and the use of cardioprotective drug therapies exist between countries. There is still considerable potential throughout Europe to raise standards of preventive care in order to reduce the risk of recurrent disease and death in patients with CHD.

Keywords

MedicineCoronary heart diseaseRisk factorPhysical therapyDiseaseDrugDrug treatmentIntervention (counseling)Internal medicinePharmacologyPsychiatry

Affiliated Institutions

Related Publications

Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study

José R. Banegas , Esther López‐García , Jean Dallongeville +9 more

In Europe, a large proportion of patients in primary prevention have CVD risk factors that remain uncontrolled, and lifestyle counselling is not well implemented; moreover, ther...

2011 European Heart Journal 352 citations

Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change With Aging?

Stanley S. Franklin , Martin G. Larson , Shehzad Akbar Khan +4 more

Background —We examined the relative importance of diastolic (DBP), systolic (SBP) and pulse pressure (PP) as predictors of coronary heart disease (CHD) risk in different age gr...

2001 Circulation 1366 citations

Is Pulse Pressure Useful in Predicting Risk for Coronary Heart Disease?

Stanley S. Franklin , Shehzad Akbar Khan , Nathan D. Wong +2 more

Background —Current definitions of hypertension are based on levels of systolic blood pressure (SBP) and diastolic blood pressure (DBP), but not on pulse pressure (PP). We exami...

1999 Circulation 1734 citations

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Donna K. Arnett , Roger S. Blumenthal , Michelle A. Albert +15 more

1. The most important way to prevent atherosclerotic vascular disease, heart failure, and atrial fibrillation is to promote a healthy lifestyle throughout life. 2. A team-based ...

2019 Circulation 4477 citations

Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum

William T. Cefalu , John B. Buse , Jaakko Tuomilehto +8 more

The International Diabetes Federation estimates that 415 million adults worldwide now have diabetes and 318 million have impaired glucose tolerance. These numbers are expected t...

2016 Diabetes Care 144 citations

Publication Info

Year: 2009
Type: article
Volume: 16
Issue: 2
Pages: 121-137
Citations: 806
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

806

OpenAlex

Cite This

APA Style

                            
                                
                                    Kornelia Kotseva, 
                                
                                    David Wood, 
                                
                                    Guy De Backer
                                
                                et al.
                            
                            (2009). 
                            EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. 
                            European Journal of Cardiovascular Prevention & Rehabilitation
                            , 16
                            (2)
                            , 121-137.
                            https://doi.org/10.1097/hjr.0b013e3283294b1d
                        

Identifiers

DOI: 10.1097/hjr.0b013e3283294b1d